Business
Research Reports Initiated on Healthcare Stocks BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
LONDON, UK / ACCESSWIRE / June 2, 2017 / Active Wall St. announces the list of stocks for to...
About this update from Resverlogix Corp.
[{"type":"text","content":"Research Reports Initiated on Healthcare Stocks BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsLONDON, UK / ACCESSWIRE / June 2, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.\n \nOn Thursday, June 01, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,469.91, 0.78% higher, with a total volume of 332,587,167 shares.\n \nAdditionally, the Healthcare index was up by 1.61%, ending the session at 67.54. \n \nActive Wall St. has initiated research reports on the following equities: BELLUS Health Inc. (TSX: BLU), Helius Medical Technologies Inc. (TSX: HSM), Resverlogix Corporation (TSX: RVX), and Crescita Therapeutics Inc. (TSX: CTX). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.\nBELLUS Health Inc. (TSX: BLU)\n \nLaval, Canada-based BELLUS Health Inc.'s stock gained 7.50%, to finish Thursday's session at $0.43 with a total volume of 36,400 shares traded. Over the last one month and the previous three months, BELLUS Health's shares have gained 38.71% and 34.38%, respectively. Shares of the Company, which engages in developing novel therapeutics for conditions with high unmet medical need, are trading above its 50-day and 200-day moving averages. BELLUS Health's 50-day moving average of $0.31 is above its 200-day moving average of $0.28. See our research report on BLU.TO at: http://www.activewallst.com/register/.\nHelius Medical Technologies Inc. (TSX: HSM)\n \nOn Thursday, shares in Newtown, Pennsylvania headquartered Helius Medical Technologies Inc. recorded a trading volume of 124,181 shares, which was higher than their three months average volume of 64,400 shares. The stock ended the day 0.48% lower at $2.08. Helius Medical Technologies' stock has surged 9.47% in the last one month and 71.90% in the previous one year. Shares of the Company, which focuses on the development ...